Time Course of Treatment for Primary Enuresis With Overactive Bladder

Purpose To characterize the course of treatment for nonmonosymptomatic enuresis with overactive bladder (OAB) in a real clinical setting. Methods Data from 111 OAB patients with moderate to severe enuresis were analyzed. The baseline analysis included a questionnaire, voiding diary, uroflowmetry wit...

Full description

Bibliographic Details
Main Authors: Young Jae Im, Jung Keun Lee, Kwanjin Park
Format: Article
Language:English
Published: Korean Continence Society 2018-06-01
Series:International Neurourology Journal
Subjects:
Online Access:http://www.einj.org/upload/pdf/inj-1836020-010.pdf
_version_ 1818191164923183104
author Young Jae Im
Jung Keun Lee
Kwanjin Park
author_facet Young Jae Im
Jung Keun Lee
Kwanjin Park
author_sort Young Jae Im
collection DOAJ
description Purpose To characterize the course of treatment for nonmonosymptomatic enuresis with overactive bladder (OAB) in a real clinical setting. Methods Data from 111 OAB patients with moderate to severe enuresis were analyzed. The baseline analysis included a questionnaire, voiding diary, uroflowmetry with postvoid residual urine measurement, and plain abdominal radiography of the kidneys, ureters, and bladder (KUB). Following standard urotherapy for 1 month, anticholinergic medication was administered with or without laxatives. Desmopressin was added if there was a partial response to OAB. Patients were followed every 3 months to evaluate the status of OAB and enuresis. Multivariate analysis was performed to identify predictors associated with the lack of complete response (CR) in enuresis at 12 months. Results Following 12 months of treatment, 64% and 88% of patients experienced at least partial response in enuresis and OAB, respectively. Urgency improved more quickly than enuresis, supporting the need to address daytime symptoms before enuresis. Seventy-nine patients (71%) had fecal impaction on KUB and/or subjective constipation. The combination of anticholinergics with either laxatives or desmopressin fared better than anticholinergics alone. Daytime incontinence and anticholinergics-only treatment were associated with a lack of CR during 12 months of treatment. Conclusions The data confirmed the validity of addressing OAB before treating enuresis. The results of this study also highlight the need to address fecal impaction. Patients should be counseled about the need for a prolonged course of treatment before starting treatment. Anticholinergics should be accompanied with either desmopressin or laxatives for better control of enuresis.
first_indexed 2024-12-12T00:10:16Z
format Article
id doaj.art-3119758e933a413899c4adfe700def3a
institution Directory Open Access Journal
issn 2093-4777
2093-6931
language English
last_indexed 2024-12-12T00:10:16Z
publishDate 2018-06-01
publisher Korean Continence Society
record_format Article
series International Neurourology Journal
spelling doaj.art-3119758e933a413899c4adfe700def3a2022-12-22T00:44:59ZengKorean Continence SocietyInternational Neurourology Journal2093-47772093-69312018-06-0122210711310.5213/inj.1836020.010721Time Course of Treatment for Primary Enuresis With Overactive BladderYoung Jae Im0Jung Keun Lee1Kwanjin Park2 Department of Urology, Seoul National University College of Medicine, Seoul, Korea Department of Urology, Seoul National University College of Medicine, Seoul, Korea Department of Urology, Seoul National University College of Medicine, Seoul, KoreaPurpose To characterize the course of treatment for nonmonosymptomatic enuresis with overactive bladder (OAB) in a real clinical setting. Methods Data from 111 OAB patients with moderate to severe enuresis were analyzed. The baseline analysis included a questionnaire, voiding diary, uroflowmetry with postvoid residual urine measurement, and plain abdominal radiography of the kidneys, ureters, and bladder (KUB). Following standard urotherapy for 1 month, anticholinergic medication was administered with or without laxatives. Desmopressin was added if there was a partial response to OAB. Patients were followed every 3 months to evaluate the status of OAB and enuresis. Multivariate analysis was performed to identify predictors associated with the lack of complete response (CR) in enuresis at 12 months. Results Following 12 months of treatment, 64% and 88% of patients experienced at least partial response in enuresis and OAB, respectively. Urgency improved more quickly than enuresis, supporting the need to address daytime symptoms before enuresis. Seventy-nine patients (71%) had fecal impaction on KUB and/or subjective constipation. The combination of anticholinergics with either laxatives or desmopressin fared better than anticholinergics alone. Daytime incontinence and anticholinergics-only treatment were associated with a lack of CR during 12 months of treatment. Conclusions The data confirmed the validity of addressing OAB before treating enuresis. The results of this study also highlight the need to address fecal impaction. Patients should be counseled about the need for a prolonged course of treatment before starting treatment. Anticholinergics should be accompanied with either desmopressin or laxatives for better control of enuresis.http://www.einj.org/upload/pdf/inj-1836020-010.pdfConstipationEnuresisAnticholinergicsUrinary bladder, Overactive
spellingShingle Young Jae Im
Jung Keun Lee
Kwanjin Park
Time Course of Treatment for Primary Enuresis With Overactive Bladder
International Neurourology Journal
Constipation
Enuresis
Anticholinergics
Urinary bladder, Overactive
title Time Course of Treatment for Primary Enuresis With Overactive Bladder
title_full Time Course of Treatment for Primary Enuresis With Overactive Bladder
title_fullStr Time Course of Treatment for Primary Enuresis With Overactive Bladder
title_full_unstemmed Time Course of Treatment for Primary Enuresis With Overactive Bladder
title_short Time Course of Treatment for Primary Enuresis With Overactive Bladder
title_sort time course of treatment for primary enuresis with overactive bladder
topic Constipation
Enuresis
Anticholinergics
Urinary bladder, Overactive
url http://www.einj.org/upload/pdf/inj-1836020-010.pdf
work_keys_str_mv AT youngjaeim timecourseoftreatmentforprimaryenuresiswithoveractivebladder
AT jungkeunlee timecourseoftreatmentforprimaryenuresiswithoveractivebladder
AT kwanjinpark timecourseoftreatmentforprimaryenuresiswithoveractivebladder